Clinical Trial Update: Changes in Tumor Tissue and Serum Biomarkers Before and After Cetuximab Combined With Preoperative Radiotherapy in Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating changes in tumor tissue and serum biomarkers after cetuximab with preoperative radiotherapy in locally advanced thoracic esophageal squ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thoracic Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Sichuan Cancer Hospital and Research Institute | Conditions: Locally Advanced Thoracic Middle-lower Segment Esophageal Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN